ARDELYX, INC. Deferred Tax Assets, Property, Plant and Equipment
ARDELYX, INC. (ARDX) had Deferred Tax Assets, Property, Plant and Equipment of $38.38 million as of 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment · last filed 2019-03-06
- 2018-12-31: Deferred Tax Assets, Property, Plant and Equipment $38.38M.
- 2017-12-31: Deferred Tax Assets, Property, Plant and Equipment $30.80M.
- 2016-12-31: Deferred Tax Assets, Property, Plant and Equipment $0.00.
| Period end | Deferred Tax Assets, Property, Plant and Equipment |
|---|---|
| 2018-12-31 | $38.38M 10-K · filed 2019-03-06 |
| 2017-12-31 | $30.80M 10-K · filed 2019-03-06 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |